Pickart L, Freedman JH, Loker WJ, Peisach J, Perkins CM, Stenkamp RE, Weinstein B (1980) Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells
The peptide does not bind to growth hormone receptors in muscle tissue, does not stimulate protein synthesis or muscle hypertrophy, shows no effects on bone metabolism or growth, demonstrates no organ enlargement or proliferative effects, and avoids the connective tissue changes associated with growth hormone
T.SagareA
COA, Purity, and Identity Documentation A certificate of analysis should be read as a batch-level record, not as a marketing sentence
A typical aggressive protocol might use 0.75mg daily for the first three days, 0.5mg for days four through seven, then 0.25mg to 0.5mg for the remainder of treatment